甲肝疫苗

  • 网络hepatitis a vaccine;HAV;HepA
甲肝疫苗甲肝疫苗
  1. 部队甲肝疫苗接种策略的成本-效用分析

    Cost-utility analysis of vaccination against HAV infection in the military

  2. 转移因子对甲肝疫苗的热稳定性及免疫佐剂作用

    The Function of Tranfer Factor to the Stability and Adjuvant of Attenuated Live Vaccine of HAV

  3. 巢式RT-PCR检测甲肝疫苗的感染性滴度研究

    Detection of hepatitis A vaccine infectivity by integrated cell culture reverse transcriptase-polymerase chain reaction

  4. 甲肝疫苗接种3a的保护率为100%。

    Three-year protection rate of hepatitis A vaccination was 100 % .

  5. 目的建立一种快速灵敏特异的检测甲肝疫苗滴度的巢式RT-PCR检测方法。

    Objective A novel integrated cell culture reverse transcriptase-polymerase chain reaction ( RT-PCR ) assay was established for hepatitis A vaccine infectivity detection .

  6. 在无甲肝疫苗接种史的人群中,抗-HAvIgG阳性率随年龄而上升,20岁以上人群的阳性率几乎都在90%以上。

    In the population without the vaccination , anti-HAV IgG positive rate increased with age . The positive rate of the population above 20 years old almost exceeded 90 % .

  7. 结论我国研制的国产H2株甲肝疫苗具有安全性好,其免疫时间长,保护率高,免疫效果肯定。

    Conclusion The domestic HA vaccine of H 2 strain possessed good safety and immune effect with a long time of immune effect and high protective rate .

  8. 结果两种甲肝疫苗在1~2岁组BCR值均最高,甲肝减毒活疫苗BCR值在各年龄组均略高于灭活疫苗。

    Results The BCR of two vaccines was highest in the group whose ages were between 1 and 2 years old . The BCR of live attenuated hepatitis A vaccine in all the groups was a bit higher than the inactivated hepatitis A vaccine .

  9. 我军甲肝疫苗接种的成本-效果分析

    Cost-effectiveness analysis of hepatitis A vaccination strategy among Chinese PLA

  10. [结论]应用WHO国民收入法评价指标可较好地对甲肝疫苗预防接种进行成本-效益分析,结果证明其经济效益显著。

    The results proved that its economic benefit was marked .

  11. 甲肝疫苗治疗慢性乙型肝炎的机制研究探讨

    Mechanisms of treatment with attenuated hepatitis A virus live vaccine in chronic hepatitis B

  12. 甲肝疫苗穴位注射治疗慢性乙型肝炎疗效的初步探讨

    Curative effect of hepatitis A vaccine point injection in the treatment of chronic hepatitis B

  13. 甲肝疫苗接种的成本效益为1:953。

    The cost benefit of HA vaccine was in the ratio of 1 to 9.53 .

  14. 结论:以减毒鼠伤寒杆菌为载体的甲肝疫苗构建成功,并可在体内外产生免疫应答。

    Conclusion Hepatitis A vaccine with attenuated Salmonella typhimurium as vector can induce immune response .

  15. 改善卫生条件和注射甲肝疫苗是抵御该疾病的最有效办法。

    Improved sanitation and the Hepatitis A vaccine are the most effective ways to combat the disease .

  16. 甲肝疫苗注射,据最近观察,对预防甲肝有较好效果。

    Armour liver vaccine injects , according to the closest observation , have better effect to preventing armour liver .

  17. 目的:构建以减毒鼠伤寒杆菌为载体的甲肝疫苗候选株,并证明其免疫源性。

    Objective To construct hepatitis A virus vaccine with attenuated Salmonella typhimurium as vector , and study its immune response .

  18. [目的]分析盐城市接种甲肝疫苗建立群体免疫屏障控制甲肝流行的效益。

    To analyze the economic benefit in building the colony immune defence by a mass vaccination of hepatitis A vaccine in Yancheng .

  19. 一些国家,包括阿根廷、中国、以色列和美国,已将甲肝疫苗列入常规儿童免疫接种。

    Several countries , including Argentina , China , Israel and the United States have introduced the vaccine in routine childhood immunizations .

  20. 是否把甲肝疫苗列入常规儿童免疫接种,视地方情况而定,包括儿童受感染风险水平。

    Whether or not to include the vaccine in routine childhood immunizations depends on the local context , including the level of risk for children .

  21. [结果]1994~1998年宝山区实施接种甲肝疫苗后,病毒性甲型肝炎发病率明显下降,测算预期减少甲型肝炎病例3581例。

    [ Results ] The incidence of hepatitis A reduced significantly through vaccinate HAV vaccine in 1994 ~ 1998 and 3581 cases of hepatitis had been reduced expectantly .

  22. 结论对适宜人群进行甲肝疫苗接种,把住病从口入关,是减少发病、控制暴发与流行的重要措施;

    Conclusion Inoculation of hepatitis A vaccines among relevant population and prevention against oral transmission pathways are important measures to reduce onsets and control the outbreak and epidemic of diseases ;

  23. 结论冻干甲肝疫苗的稳定性良好,无需低温保存、冷链运输,便于甲肝疫苗的大规模推广应用。

    Conclusion The freeze - dried HA vaccine is stable and needs no storage at low temperature or transport by cold chain . It is suitable for large - scale application .

  24. 采用WHO推荐的国民收入法评价指标,分析研究推广接种甲肝疫苗预防和控制甲肝的成本效益。

    This paper analyzed the economic benefit of prevention and control of hepatitis A by vaccinating HA vaccine in Rugao . The analysis adopted the evaluation index of national - income - method which WHO recommended .

  25. [目的]探讨甲肝疫苗穴位注射治疗慢性乙型肝炎的疗效。[方法]采用临床对照试验方法,比较甲肝疫苗穴位注射(试验组)和口服干扰素(对照组)治疗慢性乙型肝炎的临床效果。

    [ Objective ] To study curative effect of hepatitis A vaccine point injection in the treatment of chronic hepatitis B. [ Methods ] Apply clinical control method to compare clinical effect of hepatitis A vaccine point injection !

  26. 结果:北京海淀区自1998-2004年接种甲肝疫苗期间,预计共避免了729人发病。

    Results : Under the present immunization strategy , Haidian District is estimated to have prevented 729 persons from suffering HA between 1998 and 2004 . The accumulated benefit - cost ratio of the population is 1 : 0.26 ;

  27. 结论应采取的防治措施为:在适龄儿童和高危人群中接种甲肝疫苗,提高人群免疫力,同时加强健康教育和食品卫生管理。

    Conclusion Measures for the prevention and treatment of the epidemic involve inoculating children of the right age and high - risk population with hepatitis A vaccine to improve their immunity to the epidemic and strengthening health education and food hygiene management .

  28. 结果越南籍船舶,中国地方运输公司船舶,中国远洋运输总公司及下属公司船舶和外籍(越南除外)运输公司船舶上甲肝疫苗接种率分别为:40.68%、75.37%、10.32%、37.92%。

    The HAV immunization rate a-mong Crew from Vietnamese vessels , China Local transportation company vessels , China Oceangoing transportation general and Its affiliated company vessels , Foreign vessels ( exclude Vietnamese vessels ) is 40 . 68 % , 75.37 % , 11.32 % , and 37.92 % respectively .

  29. 提示H2株甲肝活疫苗在人体内增殖活跃,毒力平稳,此观察未发现毒力返祖。

    It also indicates ( shows ) that H strain live hepatitis A vaccines are active in human bodies with a stable virulence and there is no virulence reversion found in the observation .

  30. 目的观察单层及悬浮吸附工艺不同收毒时间生产的H2株甲型肝炎减毒活疫苗(以下简称甲肝活疫苗)接种恒河猴的安全性及免疫效果。

    Objective Objective To observe the safety and immune effect of live attenuated hepatitis A vaccine ( H_2 strain ) produced by mono-layer absorption and suspension absorption with different virus harvest period in rhesus monkeys .